Tue, 30th Jun 2020 18:00
STOCK EXCHANGE ANNOUNCEMENT
TOTAL VOTING RIGHTS
JPMORGAN EUROPEAN INVESTMENT TRUST PLC
Legal Entity Identifier: 549300D8SPJFHBDGXS57
Information disclosed in accordance with DTR 5.6
In conformity with the Transparency Directive the Company would like to notify the market of the following:
As at 30th June 2020, the Company's issued share capital consists of 74,259,820 Growth shares and 89,181,557 Income shares.
In accordance with Article 8 of the Company's Articles of Association, the number of voting rights per shareholder is equal to the relevant Share Voting Number for the respective class of share held, multiplied by the number of shares of that class held by the holder of that class of share.
The "Share Voting Number", in respect of a class of share, is defined as the number equal to the Net Asset Value of that pool divided by the number of shares in that pool calculated at the Voting Calculation Date.
"Voting Calculation Date" means the last day of the preceding financial year.
Therefore, the total number of voting rights in the Company is 316,509,356.
The Share Voting Numbers used to calculate the Company's voting rights are as follows:
Growth shares 2.743
Income shares 1.265
The above figure of 316,509,356 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
To calculate the nominator, shareholders are required to multiply their holding by the relevant Share Voting Number detailed above.
30th June 2020
For further information, please contact:
For and on behalf of
JPMorgan Funds Limited - Company Secretary
020 7742 4000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.